97 filings
Page 2 of 5
8-K
e3a2v1parwi
4 Jan 23
Regulation FD Disclosure
8:04am
8-K
b7sx93iipxrtior65m1
22 Dec 22
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
8:04am
8-K
lrhrae1
3 Nov 22
Collegium Reports Third Quarter 2022 Financial Results
4:01pm
8-K
f2kgkl1rus
4 Aug 22
Collegium Reports Second Quarter 2022 Financial Results
4:01pm
8-K
jkqfs2rd8g2
23 May 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K/A
q5s9hhr ew5pit
13 May 22
Financial Statements and Exhibits
4:01pm
8-K
dtsr8daqij85
10 May 22
Collegium Reports First Quarter 2022 Financial Results
4:01pm
8-K
3yes39xi862t2
13 Apr 22
Regulation FD Disclosure
8:00am
8-K
us45su2fbrbru1c7f
6 Apr 22
Departure of Directors or Certain Officers
8:10am
8-K
j2sus0yhzm03bsi2by
5 Apr 22
Regulation FD Disclosure
8:05am
8-K
01ycp9g4v a2
23 Mar 22
Collegium Completes the Acquisition of BDSI
7:55am
8-K
6yuq0 l40pk
24 Feb 22
Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results
4:01pm
8-K
zpns14d0olvo0dj
14 Feb 22
Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
7:42am
8-K
z3101vtne698z6 bd
28 Dec 21
Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
8:01am
8-K
5ocalvxv3sh094vyc
12 Nov 21
Cost Associated with Exit or Disposal Activities
8:00am
8-K
78hl2
4 Nov 21
Collegium Reports Third Quarter Fiscal 2021 Results
4:01pm
8-K
3szw4s
30 Sep 21
Departure of Directors or Certain Officers
5:10pm
8-K
68mu cpymo18d
16 Aug 21
Other Events
8:00am
8-K
1fp 2c54o2
5 Aug 21
Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
4:03pm
8-K
273lgme1
2 Jun 21
Regulation FD Disclosure
4:02pm